Rank;Global Rank;Institution;Country;Sector
1;13;Daimler AG;DEU;Companies
2;38;SAP AG;DEU;Companies
3;259;SINTEF Group;NOR;Companies
4;294;France Telecom, S.A.;FRA;Companies
5;396;BMJ Group;GBR;Companies
6;424;Robert Bosch GmbH;DEU;Companies
7;573;BASF AG;DEU;Companies
8;760;Siemens AG;DEU;Companies
8;760;VTT Technical Research Centre of Finland;FIN;Companies
10;841;STMicroelectronics;FRA;Companies
10;841;Thales Group France, S.A.;FRA;Companies
12;1133;Bayer AG Germany;DEU;Companies
12;1133;STMicroelectronics;ITA;Companies
14;1462;GlaxoSmithKline, United Kingdom;GBR;Companies
14;1462;Microsoft Research Cambridge;GBR;Companies
16;2005;Bruker Corporation;DEU;Companies
16;2005;Electricite de France, S.A.;FRA;Companies
16;2005;Infineon Technologies;DEU;Companies
16;2005;Merck KGaA, Germany;DEU;Companies
16;2005;Novartis, Switzerland;CHE;Companies
16;2005;Rolls-Royce plc;GBR;Companies
22;2984;AstraZeneca, Sweden;SWE;Companies
22;2984;AstraZeneca, United Kingdom;GBR;Companies
22;2984;Atomic Weapons Establishment;GBR;Companies
22;2984;BMW AG;DEU;Companies
22;2984;GlaxoSmithKline, Belgium;BEL;Companies
22;2984;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
22;2984;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
22;2984;IMEC International;BEL;Companies
22;2984;Novartis Farma, S.p.A., Italy;ITA;Companies
22;2984;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
22;2984;Novo Nordisk A/S;DNK;Companies
22;2984;Pfizer Inc., United Kingdom;GBR;Companies
22;2984;Philips Research Eindhoven;NLD;Companies
22;2984;Sincrotrone Trieste;ITA;Companies
22;2984;Syngenta, United Kingdom;GBR;Companies